Submitted by Anonymous (not verified) on 5 November 2026 - 14:06
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 44, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 44, Status: Authorised